Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Reexamination Certificate
2005-05-03
2005-05-03
Clardy, S. Mark (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
C514S557000, C514S574000, C514S578000, C514S891000
Reexamination Certificate
active
06887897
ABSTRACT:
Methods of controlling calcium intake and phosphate metabolism and metabolic acidosis in patients suffering from renal failure and associated hyperphosphatemia or patients predisposed to development of a hyperphosphatemic condition are provided. The method in accordance with this invention comprises administering to a patient a calcium glutarate compound. Therapeutic benefit can be realized in accordance with such method by administering the compound orally to a patient to increase available calcium and contact and bind with ingested phosphate in the patient's digestive tract, and thereby prevent its intestinal absorption.
REFERENCES:
patent: 3887533 (1975-06-01), Mukerjee
patent: 4308264 (1981-12-01), Conway et al.
patent: 4689322 (1987-08-01), Kulbe et al.
patent: 4772467 (1988-09-01), Pak
patent: 4814177 (1989-03-01), Walsdorf et al.
patent: 4851221 (1989-07-01), Pak et al.
patent: 4870105 (1989-09-01), Fordtran
patent: 5039668 (1991-08-01), Colina
patent: 5075499 (1991-12-01), Walsdorf et al.
patent: 5143732 (1992-09-01), Helbig et al.
patent: 5405308 (1995-04-01), Headley et al.
patent: 5432200 (1995-07-01), Walsdorf et al.
patent: 5514281 (1996-05-01), Boos et al.
patent: 5597815 (1997-01-01), Deluca
patent: 5746818 (1998-05-01), Yatake
patent: 5753706 (1998-05-01), Hsu
patent: 5879698 (1999-03-01), Ellenbogen et al.
patent: 5900255 (1999-05-01), Ohta et al.
patent: 5919491 (1999-07-01), Adusumilli et al.
patent: 5939406 (1999-08-01), DeLuca et al.
patent: 5952308 (1999-09-01), Nakanishi et al.
patent: 6004389 (1999-12-01), Yatake
patent: 6048901 (2000-04-01), Cleveland et al.
patent: 6077557 (2000-06-01), Gordon et al.
patent: 6077872 (2000-06-01), Yu et al.
patent: 6080431 (2000-06-01), Andon et al.
patent: 6103126 (2000-08-01), Boos et al.
patent: 6103709 (2000-08-01), Norman et al.
patent: 6160016 (2000-12-01), DeLuca
patent: 6187741 (2001-02-01), Farbood et al.
patent: 6190702 (2001-02-01), Takado et al.
Remington's Pharmaceutical Sciences (1985), pp. 1492, 1603, 1607, 1625.*
WEST online, file DWPI, RO 87637 (1985), Abstract.*
STN/CAS onine, file CAPLUS, CN 1210695 (1999), Abstract.
Alexandrides George
Walsdorf, Sr. Neill B.
Choi Frank
Clardy S. Mark
Fulbright & Jaworski LLP
Mission Pharmacal Company
LandOfFree
Calcium glutarate supplement and phosphorus binder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium glutarate supplement and phosphorus binder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium glutarate supplement and phosphorus binder will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3393393